Clinical Trials Logo
  1. Home
  2. Sleep Apnea, Central
  3. NCT02820441

Benefit of One Month Zopiclone Intake on Adaptative Servoventilation Compliance — ZODIAC  

Ventricular Dysfunction Clinical Trial

Official title:
Adaptative Servoventilation Compliance in Left Ventricular Dysfunction Patients With Central Sleep Apnea: Benefit of One Month Hypnotic (Zopiclone) Versus Placebo

Clinical Trial Summary

The study evaluate the effect of adaptative servoventilation (ASV) initiation combined with 14 days Zopiclone vs Placebo treatment in patients with central sleep apnea (CSA) syndrome.

Clinical Trial Description

ASV remain the optimal treatment for CSA in Heart Failure patients with preserved left ventricular ejection fraction (LVEF). Yet, the adaptation to the ventilation is extremely challenging and the resulting difficulties encountered to sleep induction might be a reason for dropping out. Zopiclone is indicated for the short-term treatment of insomnia where sleep initiation or sleep maintenance are prominent symptoms. In this study, Zopiclone, as sedative and hypnotic agent, is used during the ASV initiation period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02820441
Study type Interventional
Source University Hospital, Grenoble
Contact
Status Terminated
Phase Phase 4
Start date May 2016
Completion date June 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT03799133 - Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery N/A
Not yet recruiting NCT02784912 - Biomarkers in Risk Stratification of Sustainted Ventricular Tachycardia or Electrical Storm After Ablation N/A
Completed NCT01673230 - Hemodynamic Indices Predictive of a Beneficial Response to Fluid Expansion in Case of Hemodynamic Failure After Cardiac Surgery With Altered Preoperative Ejection Fraction (LVEF≤45%) N/A
Completed NCT00982397 - Safety and Clinical Performance of the Protecta ICD and CRT-D N/A
Completed NCT00187252 - Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity Therapy N/A
Recruiting NCT04848844 - The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
Recruiting NCT05851053 - Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
Recruiting NCT02644850 - Comparison of Gated Blood-pool SPECT and Echocardiogram for Ventricular Function N/A
Completed NCT00526162 - ConsultaTM CRT-D Clinical Evaluation Study N/A
Terminated NCT00524862 - Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death N/A
Withdrawn NCT00166010 - Effects of Nesiritide in Pediatric Patients With Heart Failure N/A
Completed NCT00370643 - Glucose Control in Open Heart Surgery Phase 1
Not yet recruiting NCT04068116 - Impact of Ischemic Post-conditioning N/A
Enrolling by invitation NCT03701997 - Registry to Monitor Berlin Heart EXCOR® Pediatric VAD as a Bridge to Cardiac Transplantation.
Completed NCT02497950 - HeartMate 3 ELEVATE™ Registry
Recruiting NCT05934071 - Effects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF.
Recruiting NCT02816047 - Austrian Wearable Cardioverter Defibrillator Registry
Completed NCT04634708 - The Use of the EXCOR Active Driving Unit for Mobilization of Pediatric Patients With Ventricular Assist Device Support
Completed NCT00893360 - CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction Phase 1
Completed NCT01452165 - Peripheral Artery Disease in Vastmanland